OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Megan Sanders: One Year of Progress in Australia’s Lung Cancer Screening Program

NK-Cell Immunotherapy: The Next Frontier in Cancer Treatment

KRAS Grows Up: The Breakthroughs and the Reckonings

Akeso and MSKCC collaborate around a new Treatment for Gastric and GEJ adenocarcinoma - Akeso Biopharma

Farina Arreguin: AYA Roundtable for Young Cancer Patients

Oncology News, Insights, Stories by OncoDaily

Garo Armen
OncoDaily Magazine

The Man Who Challenged Reality. For 32 years, Garo Armen has pursued a vision many believed was impossible.

Gedatolisib
Breast Oncology

FDA Approves Gedatolisib - Based Therapy for HR+/HER2− Advanced Breast Cancer Without PIK3CA Mutation

REVTORPYK
Voices

The Oncology Community Discusses the Recent FDA Approval of REVTORPYK

Nara Smith Opens Up About Her Two-Year-Old Daughter’s Cancer Battle

Laura Towart : How Much Younger Can You Get in Six Months?

2026 IBRI Global Forum on Science, Philanthropy, and Investment

Rafael Fonseca Reflects on “Many and Multiple Myeloma(s)” 23 Years Later

Asem Mansour։ CAR-T Therapy Manufacturing Advances in Jordan

Promising New Approach to Treating Bladder Cancer - Parker Institute for Cancer Immunotherapy

FDA Approves Subcutaneous Isatuximab for Multiple Myeloma

Voices
Estela Rodriguez

Estela Rodriguez: Good News Today for Patients With EGFR Exon 20 Insertion-positive Lung Cancer

Episode 1 of Innovations in Oncology: Understanding Novel and Emerging Immunotherapies is Live! - ESMO

Joshua Omale: Why the Future of African Children is Being Shaped Long Before They Can Choose It

World Cup Semi-Finals Bring Colleagues Together in Boston - Servier Pharmaceuticals

Eftychia Tataridou: A Powerful World Glioblastoma Awareness Day Message

Gilberto de Lima Lopes Junior: A Perspective on Return-to-Office Mandates and Telemedicine

Juan W. Valle: A New App to Connect Cholangiocarcinoma Patients with Healthcare Providers

FDA Approvals
Subcutaneous Isatuximab Multiple Myeloma

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Asparaginase Drug Monitoring in Pediatric ALL: The Brazilian Experience - Resonance

Resonance

17 Jul
Pediatric ALL

International Society for Experimental Hematology (ISEH) 55th Annual Scientific Meeting

International Society for Experimental Hematology (ISEH)

27 Aug
ISEH

2026 IBRI Global Forum on Science, Philanthropy, and Investment

Indiana Biosciences Research Institute (IBRI)

29 Oct
IBRI Global forum

HER2 and Colorectal Cancer: What Advocates Need to Know

Global Colon Cancer Association

29 Jul
Colorectal Cancer

ESSO Advanced Course on the Treatment of Peritoneal Surface Malignancy

European Society of Surgical Oncology

15 Oct
Peritoneal Surface Malignancy

Immune-oncology
KEYNOTE-C93

KEYNOTE-C93: Pembrolizumab May Replace Chemotherapy in dMMR Endometrial Cancer

NK-Cell Immunotherapy: The Next Frontier in Cancer Treatment

ChemRNA: A New Generation of Simplified RNA Vaccines for Cancer Immunotherapy

10 Must-Read Posts in Immuno-Oncology This Week

FDA Approves Perioperative Pembrolizumab Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

FDA Approves Subcutaneous Isatuximab for Multiple Myeloma

FDA Immunotherapy Approvals: First Half of 2026

Gastrointestinal-Oncology
TOPAZ-1

TOPAZ-1 Post Hoc Analysis: Durvalumab Plus GemCis in Advanced Biliary Tract Cancer

10 Must-Read Posts In GI Oncology This Week

From “Most Promising” to Phase 3: Up to $340M to Advance BOT/BAL in MSS Colon Cancer

Highlights of ESMO GI 2026 in Colorectal Cancer with Davide Ciardiello

Agenus Announces Up to $340M Financing to Advance Phase 3 ROBBIN of Neoadjuvant BOT/BAL in MSS Colon Cancer

Disitamab Vedotin, Tislelizumab, and S-1 Deliver High Response Rates in HER2-Overexpressing Advanced Gastric/GEJ Cancer

WHO Global Cancer Report 2026: GI Cancers Show the Cost of Delayed Prevention, Diagnosis, and Access

Breast-Oncology
Tucatinib

Tucatinib Plus Trastuzumab Deruxtecan Shows Activity but No Clear Added Benefit in HER2+ Advanced Breast Cancer

FDA Approves Gedatolisib - Based Therapy for HR+/HER2− Advanced Breast Cancer Without PIK3CA Mutation

SERENA-6: Switching to Camizestrant at ESR1 Mutation Emergence Extends First-Line Benefit in HR+/HER2− Advanced Breast Cancer

Germline Multigene Testing May Identify Higher-Risk Invasive Lobular Breast Cancer

Breast Cancer Incidence Is Rising Rapidly Among Asian American, Native Hawaiian, and Pacific Islander Women

NCCN Breast Cancer Version 4.2026: Metastatic Treatment Moves Further Toward Biomarker-Driven Sequencing

IM-MS Irradiation Reduced Breast Cancer Mortality but Did Not Improve Overall Survival in Node-Negative Breast Cancer

Lung-Oncology
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan Plus Pembrolizumab Meets Phase III Endpoint in First-Line PD-L1-Negative Non-Squamous NSCLC

ADC-Related Interstitial Lung Disease: A Class-Relevant Toxicity That Requires Early Recognition

Risvutatug Rezetecan Meets Overall Survival Endpoint in Phase III SCLC Trial in China

Comprehensive Genomic Profiling Delays in Lung Cancer: Biopsy-to-Order Time Remains the Biggest Barrier

Pretreatment SUVmax May Help Identify Which Early-Stage NSCLC Patients Benefit From Consecutive Daily SBRT

Can AI-Supported Navigation Help Close the Lung Nodule Follow-Up Gap?

WHO Global Cancer Report 2026: Lung Cancer Shows Why Prevention Still Saves the Most Lives

Oncology Tech
ADC

After TROP2 and HER2, Is B7-H3 the Next Big ADC Target?

KRAS Grows Up: The Breakthroughs and the Reckonings

Chris Boshoff: FDA Approves First Platinum-Free Perioperative Regimen for Muscle-Invasive Bladder Cancer

FDA Accepts Immunome's NDA for Varegacestat in Desmoid Tumors, Setting Up an April 2027 Decision

Novartis' $1.5B Myricx deal is a preclinical bet on a brand-new ADC payload

Claude Science: What Anthropic's New Research Workbench Actually Does for Oncology

Is the First AI-Designed Cancer Drug About to Be Approved?

Hematology
PTCL Peripheral T-cell lymphomas

Peripheral T-Cell Lymphomas (PTCL): Another Evolving Lymphoma Story

Europe Opens the Door to Epcoritamab-R² in Early Relapsed Follicular Lymphoma: A Candidate for a New 2L Standard?

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

What the WHO Global Status Report on Cancer 2026 Means for Hematology

Outpatient Cilta-cel for Multiple Myeloma: Initial Experience in Carefully Selected Patients

Marginal Zone Lymphoma (MZL): Chronic Immune Stimulation, Heterogeneity and Beyond

Phase 3 TRIANGLE: Reassessing the Role of ASCT in Frontline Ibrutinib-Containing Therapy for MCL

Radiotherapy
Four-Arc Coplanar VMAT

Four-Arc Coplanar VMAT Emerges as a Practical Option for Hippocampal-Sparing Whole-Brain Radiotherapy

Unresectable Stage III NSCLC: Precision Redefines Care

A Looming Collapse: Radiation Oncology’s Access Crisis Is No Longer Theoretical 2026

OLIGOPELVIS 2 Shows Acceptable Toxicity With Salvage Nodal Radiotherapy

Early SBRT Before Chemoimmunotherapy Shows Promise in Borderline Resectable and Locally Advanced Pancreatic Cancer

HYPORT Adjuvant Trial Evaluates Quality of Life After Nodal Radiotherapy

Can SABR Replace Surgery in Selected Low-Risk Breast Cancer?

OncoDaily TV
Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Kefah Mokbel

Kefah Mokbel: Can Diet Influence Cancer Risk and Outcomes?

Empowering Oncologists: How to make the most of your fellowship?

Empowering Oncologists: How to make the most of your fellowship?

STAMP Inhibitors Against CML: Prof. Timothy Hughes

STAMP Inhibitors Against CML: Prof. Timothy Hughes

Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

Not To Miss
2026 IBRI Global Forum on Science, Philanthropy, and Investment

2026 IBRI Global Forum on Science, Philanthropy, and Investment

15 Posts Not To Miss From Best of ASCO Africa 2026

Top Growing Medical Universities in Africa: 2026 Edition by BIGR

WHO Calls for Urgent Action as New Cancer Cases Are Projected to Nearly Double by 2050

20 Posts Not To Miss From ESMO GI 2026, Part 2

20 Posts Not To Miss From ESMO GI 2026, Part 1

Top Growing Medical Universities in Asia: 2026 Edition by BIGR

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
MCL Mantle cell lymphoma, BTK inhibitors

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): Evolving Biology and Modern Therapeutic Paradigms

CancerWorld

Oncologists
Roshan Daniel

Roshan Daniel

Oncologists Location Thiruvananthapuram, India
Nazik Hammad

Nazik Hammad

Oncologists Location Toronto, Canada
Edoardo Francini

Edoardo Francini

Oncologists Location Florence, Italy
Rachna Shroff

Rachna Shroff

Oncologists Location Tucson, USA
Florian Lordick

Florian Lordick

Oncologists Location Leipzig, Germany
Kathleen Schmeler

Kathleen Schmeler

Oncologists Location Houston, USA
Rahat Ul Ain

Rahat Ul Ain

Oncologists Location Lahore, Pakistan
Ilya Tsimafeyeu

Ilya Tsimafeyeu

Oncologists Location Moscow, Russia

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports & Case Series

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports & Case Series